
|Videos|April 23, 2018
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Intermediate-Risk Newly Diagnosed Metastatic Renal Cell Carcinoma
Advertisement
Case Scenario: A 52-year old male with mRCC
February 2018
- A 52-year old Caucasian man presented to his physician complaining of severe left-sided back pain
- Laboratory findings: mild anemia, otherwise WNL
- CT scan of the abdomen and pelvis showed a large left renal mass, several small lytic lesions in the lumbar and thoracic vertebrae, and a small pulmonary nodule
- The patient underwent cytoreductive nephrectomy
- Diagnosis; stage IV clear-cell renal cell carcinoma; good-risk
- He received radiation therapy to his spinal lesions and was then started on cabozantinib 60 mg daily
- The patient reported moderate nausea and vomiting and diarrhea after 6 weeks on therapy; he continues to do well with improved tolerance after dose adjustment to 40 mg
- Imaging at 3 months showed a significant decrease in size of the pulmonary nodule
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5









































